(NASDAQ:TRIB), DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced new findings from its latest pre-pivotal trial, highlighting significant improvements in first-day performance for its next-generation continuous glucose monitoring (CGM) system. The latest analysis confirms […]

(NASDAQ:GTX), PLYMOUTH, Mich. and ROLLE, Switzerland, Feb. 06, 2025 (GLOBE NEWSWIRE) — Garrett Motion Inc. (Nasdaq: GTX), a leading provider of differentiated automotive technology, today announced that it plans to release its fourth quarter financial results on Thursday, February 20, 2025, prior to the opening of the market trading in the United States. Garrett will

LONDON, Feb. 06, 2025 (GLOBE NEWSWIRE) — Lewis Pugh, the world-renowned endurance swimmer and advocate for ocean protection, will deliver the closing keynote address at Optimove's 2025 Premier User Conference, Optimove Connect. As the first person to complete long-distance swims in every ocean of the world, Pugh will share his extraordinary insights on achieving the

(NASDAQ:FXNC), STRASBURG, Va., Feb. 06, 2025 (GLOBE NEWSWIRE) — First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), the bank holding company of First Bank (the “Bank”), reported an unaudited consolidated net loss of $933 thousand and basic and diluted loss per common share of $0.10 for the fourth quarter of 2024, and adjusted

(TSX-V:VRR),(Boerse Frankfurt – Freiverkehr:5VR.F),(Boerse Frankfurt – Freiverkehr:5VR),(OTC US:VRRCF),(Other OTC:VRRCF), VANCOUVER, British Columbia, Feb. 06, 2025 (GLOBE NEWSWIRE) — VR Resources Ltd. (TSX.V: VRR, FSE: 5VR; OTCQB: VRRCF), the “Company“, or “VR“, is pleased to provide an update on its ongoing exploration activities at the Silverback and Empire projects in northwestern Ontario. Two holes are complete

(NASDAQ:RLMD), Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB Phase 2a results signaled improvement in Tourette symptoms, quality of life and robust overall safety, supporting Sepranolone as a new potential first line treatment option for TS Sepranolone (isoallopregnanolone) is a

(NASDAQ:QNTM),(CNSX:QNTM),(Boerse Frankfurt – Freiverkehr:0K91), TORONTO, Feb. 06, 2025 (GLOBE NEWSWIRE) — BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company“), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced that its licensee Celly Nutrition Corporation, the company behind unbuzzdTM – the scientifically-proven

(TSX:NFI),(OTC US:NFYEF),(Other OTC:NFYEF),(TSX:NFI-DB),(TSX:NFI.DB), ST. CLOUD, Minn., Feb. 06, 2025 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI) a leading independent bus and coach manufacturer and a leader in zero-emission electric mass mobility solutions, subsidiary New Flyer of America Inc. (New Flyer), today announced a significant contract award for a mix

(NASDAQ:RIME), Investors From December $9.5 Million Public Offering Exercise All Outstanding Series B Warrants Fort Lauderdale, FL, Feb. 06, 2025 (GLOBE NEWSWIRE) — Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME), an AI-driven technology and consumer electronics holding company, today announced that all outstanding Series B cashless warrants have been fully exercised. These warrants were issued in

(NASDAQ:ZENA),(Boerse Frankfurt – Freiverkehr:49Q), VANCOUVER, British Columbia, Feb. 06, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions, announces that ZenaDrone will commence testing work this quarter on a high density